The Application dimension of the IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing segmentation delineates how investment is allocated across core manufacturing functions. Production dominates, capturing roughly 40 % of spend, as real‑time equipment monitoring, predictive maintenance, and closed‑loop control systems drive efficiency and compliance. Quality Control follows with about 25 % of the budget, reflecting the need for continuous sensor‑based verification of critical parameters such as temperature, humidity, and sterility, which directly affect batch release decisions. Supply Chain accounts for 20 % of the outlay, where IoT enables end‑to‑end traceability, cold‑chain monitoring, and inventory optimization across raw material sourcing to finished‑goods distribution. Finally, R&D absorbs the remaining 15 %, supporting laboratory automation, high‑throughput screening, and digital twins that accelerate formulation development. This application‑centric taxonomy clarifies the relative weight of each functional area within the overall market size, informing strategic allocation of resources.